DK143491D0 - Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion - Google Patents

Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion

Info

Publication number
DK143491D0
DK143491D0 DK911434A DK143491A DK143491D0 DK 143491 D0 DK143491 D0 DK 143491D0 DK 911434 A DK911434 A DK 911434A DK 143491 A DK143491 A DK 143491A DK 143491 D0 DK143491 D0 DK 143491D0
Authority
DK
Denmark
Prior art keywords
phenylacetylaminopiperidinaa
oen
dion
preparing
Prior art date
Application number
DK911434A
Other languages
English (en)
Other versions
DK143491A (da
Inventor
Stanislaw R Burzynski
Original Assignee
Stanislaw R Burzynski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski
Publication of DK143491D0 publication Critical patent/DK143491D0/da
Publication of DK143491A publication Critical patent/DK143491A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK143491A 1981-07-02 1991-08-06 Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion DK143491A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27972881A 1981-07-02 1981-07-02
US06/330,383 US4470970A (en) 1981-07-02 1981-12-15 Purified antineoplaston fractions and methods of treating neoplastic disease

Publications (2)

Publication Number Publication Date
DK143491D0 true DK143491D0 (da) 1991-08-06
DK143491A DK143491A (da) 1991-08-06

Family

ID=26959856

Family Applications (2)

Application Number Title Priority Date Filing Date
DK242082A DK162813C (da) 1981-07-02 1982-05-28 Fremgangsmaade til fremstilling af et praeparat til at haemme vaeksten af neoplastiske celler
DK143491A DK143491A (da) 1981-07-02 1991-08-06 Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK242082A DK162813C (da) 1981-07-02 1982-05-28 Fremgangsmaade til fremstilling af et praeparat til at haemme vaeksten af neoplastiske celler

Country Status (14)

Country Link
US (1) US4470970A (da)
EP (1) EP0069232B1 (da)
JP (3) JPH0729925B2 (da)
AU (1) AU551109B2 (da)
CA (1) CA1188218A (da)
DE (1) DE3273952D1 (da)
DK (2) DK162813C (da)
ES (1) ES8502417A1 (da)
HK (1) HK30289A (da)
IL (1) IL65960A (da)
MY (1) MY102918A (da)
NO (1) NO163595C (da)
NZ (1) NZ200805A (da)
SG (1) SG4489G (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559325A (en) * 1981-12-15 1985-12-17 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4593038A (en) * 1985-04-03 1986-06-03 Burzynski Stanislaw R Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
US4705796A (en) * 1986-08-25 1987-11-10 Stereochemical Genetics, Inc. Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
AU7742491A (en) * 1990-04-12 1991-11-11 Stereo-Chemical Genetics, Inc. Synthetic piperidinediones with cytostatic activity
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5089508A (en) * 1990-09-04 1992-02-18 Burzynski Stanislaw R Methods for treating aids
US5116622A (en) * 1990-09-12 1992-05-26 Burzynski Stanislaw R Methods for treating parkinson's disease
US6037376A (en) * 1991-10-21 2000-03-14 The United States Of America As Represented By The Department Of Health And Human Services Methods for therapy of cancer
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
AU2804592A (en) * 1991-10-21 1993-05-21 Dvorit Samid Compositions and methods for therapy and prevention of cancer, aids, and anemia
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
US5783605A (en) * 1995-02-27 1998-07-21 Kuo; Sheng-Chu Helper inducers for differentiation therapy and chemoprevention of cancer
EP0906088B1 (en) * 1996-05-14 2005-11-23 BURZYNSKI, Stanislaw R. Liposomal antineoplaston therapies with markedly improved antineoplastic activity
EP1886677A1 (en) * 1996-07-26 2008-02-13 Susan P. Perrine Use of an inducing agent for the treatment of blood, viral and cellular disorders
US6258849B1 (en) * 1998-07-23 2001-07-10 Stanislaw R. Burzynski Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
AU1553799A (en) * 1998-12-18 2000-07-12 Chang, Ming-Lieh Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof
US6987131B1 (en) * 2000-06-26 2006-01-17 Burzynski Stanislaw R Phenylacetic acid compositions for treating or preventing hypercholesterolemia
WO2004012662A2 (en) * 2002-08-01 2004-02-12 Aesgen, Inc. Improved treatment of cancer with glutamine
US7087219B2 (en) * 2003-05-28 2006-08-08 Stanislaw R. Burzynski Toothpaste containing anticancer agents
US20060246016A1 (en) * 2003-05-28 2006-11-02 Burzynski Stanislaw R Toothpaste containing anticancer agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE463549A (da) *
GB2003887A (en) * 1977-09-06 1979-03-21 Nyegaard & Co As Isolation of peptides from urine
JPS57115330A (en) * 1981-01-08 1982-07-17 Toshiba Mach Co Ltd Forming process for thick plastic products and its metal mold
JP2897285B2 (ja) * 1989-10-19 1999-05-31 東洋紡績株式会社 熱可塑性樹脂フィルム積層物

Also Published As

Publication number Publication date
JPH0532548A (ja) 1993-02-09
NO822218L (no) 1983-01-03
HK30289A (en) 1989-04-21
IL65960A0 (en) 1982-09-30
JPS5810521A (ja) 1983-01-21
AU8423982A (en) 1983-01-06
ES512894A0 (es) 1985-01-01
ES8502417A1 (es) 1985-01-01
DK242082A (da) 1983-01-03
CA1262907C (da) 1989-11-14
JPH0729925B2 (ja) 1995-04-05
NO163595B (no) 1990-03-19
AU551109B2 (en) 1986-04-17
DK162813C (da) 1992-05-04
DK143491A (da) 1991-08-06
JPH0558886A (ja) 1993-03-09
DK162813B (da) 1991-12-16
IL65960A (en) 1985-11-29
EP0069232A2 (en) 1983-01-12
US4470970A (en) 1984-09-11
NO163595C (no) 1990-06-27
EP0069232B1 (en) 1986-10-29
JPH0739390B2 (ja) 1995-05-01
CA1188218A (en) 1985-06-04
MY102918A (en) 1993-03-31
SG4489G (en) 1989-05-26
NZ200805A (en) 1986-08-08
JPH0780764B2 (ja) 1995-08-30
DE3273952D1 (en) 1986-12-04
EP0069232A3 (en) 1984-07-04

Similar Documents

Publication Publication Date Title
DK280182A (da) Fremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
DK143491D0 (da) Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion
DK210083D0 (da) Fremgangsmade til fremstilling af 6a,10a-trans-hexahydrodibenzopyranoner
DK183583D0 (da) Fremgangsmade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner
DK262782A (da) Fremgangsmaade til fremstilling af n-dihydrothiazolyl-3-quinolincarboxamidderivater
DK157855C (da) Fremgangsmaade til fremstilling af 2,3-dichlor-5-trichlormethylpyridin
DK159681A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-alfa-(polyfluoralkyl)-1h-pyrrol-2-methanaminer
DK370582A (da) Fremgangsmaade til fremstilling af 2-beta-d-ribofuranosylthiazol-4-carboxamid
DK115581A (da) Fremgangsmaade til fremstilling af pyrimidylquinazoliner
DK159309C (da) Fremgangsmaade til fremstilling af 4-metyl-5-alkylthiometyl-imidazoler
DK113483A (da) Fremgangsmaade til fremstilling af 3,4-diphenyl-5-methylpyrazolderivater
DK154207C (da) Fremgangsmaade til fremstilling af 1,8-dihydroxy-10-acyl-9-anthroner
DK454579A (da) Fremgangsmaade til fremstilling af 6-piperidino-2,4-diaminopyrimidin-3-oxid
DK283381A (da) Fremgangsmaade til fremstilling af 1,2,4-triazinylthiomethyl-3-cephem-sulfoxid
DK40883D0 (da) Fremgangsmade til fremstilling af benzothienylallylaminer
DK449881A (da) Fremgangsmaade til fremstilling af moroxydinphenoxyisobutyrater
DK153488C (da) Fremgangsmaade til fremstilling af 5,6,7,7a-tetrahydro-4h-thieno(3,2-c-)-pyridin-2-onderivater
DK281384D0 (da) Fremgangsmaade til fremstilling af 2-alkyl-1,4-butandioler
DK513580A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-alfa (polyhalogenalkyl)-1h-imidazol-2-methanoler
DK159681C (da) Fremgangsmaade til fremstilling af 2-substituerede 5-nitroso-4,6-diamino-pyrimidiner
DK97682A (da) Fremgangsmaade til fremstilling af 1-(1,3-benzodioxol-5-yl)-2-pyrrolidinon
DK446683A (da) Fremgangsmaade til fremstilling af 6-anilino-5,8-quinoxalindioner
DK26881A (da) Fremgangsmaade til fremstilling af alfaketocarboxylsyre-n-tert. butylamider
DK446583A (da) Fremgangsmaade til fremstilling af isoquinolin-5,8-quinoner
DK375480A (da) Fremgangsmaade til fremstilling af 1,2,4-triazol-3-thioler

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment